P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000969396.26114.b3 |
| _version_ | 1827331272105525248 |
|---|---|
| author | Othman Al-Sawaf Min-Hua Jen Lisa Hess Jiewen Zhang Benjamin Goebel John Pagel Toby Eyre |
| author_facet | Othman Al-Sawaf Min-Hua Jen Lisa Hess Jiewen Zhang Benjamin Goebel John Pagel Toby Eyre |
| author_sort | Othman Al-Sawaf |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:33:43Z |
| format | Article |
| id | doaj.art-a5d94a79876b482c952117ed1f2cbf6c |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:33:43Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-a5d94a79876b482c952117ed1f2cbf6c2024-03-03T10:07:33ZengWileyHemaSphere2572-92412023-08-017e26114b310.1097/01.HS9.0000969396.26114.b3202308003-00523P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOROthman Al-Sawaf0Min-Hua Jen1Lisa Hess2Jiewen Zhang3Benjamin Goebel4John Pagel5Toby Eyre61 University Hospital, Cologne, Germany2 Eli Lilly and Company Corporate Center, Erlwood, United Kingdom3 Eli Lilly and Company Corporate Center, Indianapolis, United States4 TechData Service Company, King of Prussia, United States5 Eli Lilly and Company, Bad Homburg, Germany6 Loxo@Lilly, Indianapolis, United States7 Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdomhttp://journals.lww.com/10.1097/01.HS9.0000969396.26114.b3 |
| spellingShingle | Othman Al-Sawaf Min-Hua Jen Lisa Hess Jiewen Zhang Benjamin Goebel John Pagel Toby Eyre P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR HemaSphere |
| title | P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title_full | P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title_fullStr | P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title_full_unstemmed | P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title_short | P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title_sort | p623 matching adjusted indirect comparison maic of pirtobrutinib vs venetoclax continuous monotherapy in patients with relapsed refractory cll previously treated with a covalent btk inhibitor |
| url | http://journals.lww.com/10.1097/01.HS9.0000969396.26114.b3 |
| work_keys_str_mv | AT othmanalsawaf p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT minhuajen p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT lisahess p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT jiewenzhang p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT benjamingoebel p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT johnpagel p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT tobyeyre p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor |